Literature DB >> 29768691

Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assay.

A Akram1, S M R Islam1, S U Munshi1, S Tabassum1.   

Abstract

Transmission of Hepatitis B Virus (HBV) usually occurs due to the transfusion of blood or blood products from chronic HBV (CHB) or occult HBV-infected (OBI) patients. Besides serological tests, e.g. HBsAg and anti- HBc (total), detection of HBVDNA is necessary for the diagnosis of OBI patients. Different nucleic acid tests (NATs) including real- time-Polymerase Chain Reaction (qPCR) are used to detect HBV- DNA. The NATs are expensive and require technical expertise which are barriers to introduce them in resource-limited settings. This study was undertaken to evaluate the use of Loop-Mediated Isothermal Amplification (LAMP) assay as an alternative to qPCR for the detection of HBV-DNA in CHB and potential OBI patients in resource-limited settings. Following the published protocols with some modifications, a LAMP assay was developed for detection of HBV-DNA by either using a heat block followed by detection in an agarose gel or using a qPCR thermocycler. The LAMP assay was applied to supernatant prepared from heat-treated serum collected from CHB and potential OBI patients. HBV viral load in serum was measured by qPCR using a single-step HBV-DNA quantification kit. Among 200 samples tested, qPCR was capable to detect HBV-DNA in 25.5% of cases, whereas LAMP assay detected HBV-DNA in 43.5% cases. The qPCR was able to detect 11 (9.16%) potential OBI cases, whereas LAMP assay identified HBV-DNA in 43 (35.83%) cases. In addition to tests for HBsAg and/or anti-HBc (total), detection of HBV-DNA by LAMP assay may aid in preventing post-transfusion HBV infection in resource-limited settings.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990OBIzzm321990; HBV-DNA; LAMP assay; qPCR

Mesh:

Substances:

Year:  2018        PMID: 29768691     DOI: 10.1111/jvh.12931

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects.

Authors:  Dangsheng Xiao; Ju Wang; Zhitao Chen; Xiuyuan Jin; Yirui Xie; Dong Yan; Jiezuan Yang
Journal:  BMC Infect Dis       Date:  2021-01-23       Impact factor: 3.090

2.  Rapid Detection of Hepatitis B Virus in Blood Samples Using a Combination of Polymerase Spiral Reaction With Nanoparticles Lateral-Flow Biosensor.

Authors:  Lin Lin; Jinshuai Guo; Haiyang Liu; Xiaofeng Jiang
Journal:  Front Mol Biosci       Date:  2021-01-07

Review 3.  Occult Hepatitis B Virus Infection: An Update.

Authors:  Carlo Saitta; Teresa Pollicino; Giovanni Raimondo
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

4.  Flexible Terahertz Metamaterial Biosensor for Ultra-Sensitive Detection of Hepatitis B Viral DNA Based on the Metal-Enhanced Sandwich Assay.

Authors:  Yumin Li; Xiaojing Wang; Yu Liu; Weidong Jin; Huiyan Tian; Fengxin Xie; Ke Xia; Xiuming Zhang; Weiling Fu; Yang Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-08-05

5.  A rapid and sensitive recombinase aided amplification assay to detect hepatitis B virus without DNA extraction.

Authors:  Xin-Xin Shen; Fang-Zhou Qiu; Li-Ping Shen; Ten-Fei Yan; Meng-Chuan Zhao; Ju-Ju Qi; Chen Chen; Li Zhao; Le Wang; Zhi-Shan Feng; Xue-Jun Ma
Journal:  BMC Infect Dis       Date:  2019-03-05       Impact factor: 3.090

6.  CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV.

Authors:  Ronghua Ding; Jinzhao Long; Mingzhu Yuan; Xue Zheng; Yue Shen; Yuefei Jin; Haiyan Yang; Hao Li; Shuaiyin Chen; Guangcai Duan
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.